A detailed history of Advisor Group Holdings, Inc. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 4,322 shares of MRVI stock, worth $22,560. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,322
Previous 3,975 8.73%
Holding current value
$22,560
Previous $28,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.84 - $9.73 $2,373 - $3,376
347 Added 8.73%
4,322 $35,000
Q2 2024

Aug 13, 2024

BUY
$6.87 - $11.34 $817 - $1,349
119 Added 3.09%
3,975 $28,000
Q1 2024

May 10, 2024

BUY
$5.11 - $8.76 $4,236 - $7,262
829 Added 27.39%
3,856 $33,000
Q4 2023

Feb 12, 2024

SELL
$4.7 - $9.87 $13,512 - $28,376
-2,875 Reduced 48.71%
3,027 $19,000
Q3 2023

Nov 13, 2023

BUY
$9.14 - $12.85 $23,380 - $32,870
2,558 Added 76.5%
5,902 $59,000
Q2 2023

Aug 10, 2023

SELL
$12.09 - $15.0 $16,611 - $20,610
-1,374 Reduced 29.12%
3,344 $41,000
Q1 2023

May 12, 2023

BUY
$12.99 - $16.48 $6,806 - $8,635
524 Added 12.49%
4,718 $66,000
Q4 2022

Feb 10, 2023

BUY
$12.5 - $24.78 $8,475 - $16,800
678 Added 19.28%
4,194 $60,000
Q3 2022

Nov 14, 2022

BUY
$20.6 - $30.37 $8,755 - $12,907
425 Added 13.75%
3,516 $90,000
Q2 2022

Aug 10, 2022

SELL
$26.05 - $37.48 $604,229 - $869,348
-23,195 Reduced 88.24%
3,091 $88,000
Q1 2022

May 04, 2022

BUY
$24.46 - $40.92 $578,845 - $968,371
23,665 Added 902.9%
26,286 $928,000
Q3 2021

Nov 05, 2021

SELL
$36.8 - $60.62 $1.09 Million - $1.8 Million
-29,671 Reduced 91.88%
2,621 $128,000
Q2 2021

Aug 02, 2021

BUY
$32.46 - $45.0 $918,682 - $1.27 Million
28,302 Added 709.32%
32,292 $1.35 Million
Q1 2021

May 13, 2021

BUY
$25.8 - $38.49 $54,102 - $80,713
2,097 Added 110.78%
3,990 $142,000
Q4 2020

Feb 10, 2021

BUY
$24.5 - $30.86 $46,378 - $58,417
1,893 New
1,893 $53,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $687M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.